RetinalGenix Technologies Inc.
OTC: RTGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jerry Katzman
- Headquarters
- Apollo Beach, United States
- IPO year
- 2022
- Market cap
- $75.4M
- Website
- https://retinalgenix.com
Loading RTGN…
Loading profile data…Frequently asked questions about RTGN
What does RetinalGenix Technologies Inc. (RTGN) do?
RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their p...
Where does RTGN trade?
RetinalGenix Technologies Inc. (RTGN) trades on the Other OTC.
What sector is RTGN in?
RetinalGenix Technologies Inc. (RTGN) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of RetinalGenix Technologies Inc.?
Jerry Katzman is the chief executive officer of RetinalGenix Technologies Inc. (RTGN).
Where is RetinalGenix Technologies Inc. headquartered?
RetinalGenix Technologies Inc. is headquartered in United States.
Does RTGN pay a dividend?
RetinalGenix Technologies Inc. (RTGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RTGN go public?
RetinalGenix Technologies Inc. (RTGN) completed its initial public offering in 2022.